. . . . . . . . . "a(SCHEM:Thiazolidinedione) -| a(CHEBI:hemoglobin)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "However, treatment with these compounds (TZDs) is associated with several undesirable side effects, including edema, weight gain, decreased hematocrit and hemoglobin and increased alanine aminotransferase activity" . . "Selventa" . . . . "2014-07-03T14:30:29.049+02:00"^^ . . .